Literature DB >> 33705493

Direct interaction of HIV gp120 with neuronal CXCR4 and CCR5 receptors induces cofilin-actin rod pathology via a cellular prion protein- and NOX-dependent mechanism.

Lisa K Smith1, Isaac W Babcock2, Laurie S Minamide2, Alisa E Shaw2, James R Bamburg2, Thomas B Kuhn1,2.   

Abstract

Nearly 50% of individuals with long-term HIV infection are affected by the onset of progressive HIV-associated neurocognitive disorders (HAND). HIV infiltrates the central nervous system (CNS) early during primary infection where it establishes persistent infection in microglia (resident macrophages) and astrocytes that in turn release inflammatory cytokines, small neurotoxic mediators, and viral proteins. While the molecular mechanisms underlying pathology in HAND remain poorly understood, synaptodendritic damage has emerged as a hallmark of HIV infection of the CNS. Here, we report that the HIV viral envelope glycoprotein gp120 induces the formation of aberrant, rod-shaped cofilin-actin inclusions (rods) in cultured mouse hippocampal neurons via a signaling pathway common to other neurodegenerative stimuli including oligomeric, soluble amyloid-β and proinflammatory cytokines. Previous studies showed that synaptic function is impaired preferentially in the distal proximity of rods within dendrites. Our studies demonstrate gp120 binding to either chemokine co-receptor CCR5 or CXCR4 is capable of inducing rod formation, and signaling through this pathway requires active NADPH oxidase presumably through the formation of superoxide (O2-) and the expression of cellular prion protein (PrPC). These findings link gp120-mediated oxidative stress to the generation of rods, which may underlie early synaptic dysfunction observed in HAND.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33705493      PMCID: PMC7951892          DOI: 10.1371/journal.pone.0248309

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  111 in total

1.  Production and use of replication-deficient adenovirus for transgene expression in neurons.

Authors:  L S Minamide; A E Shaw; P D Sarmiere; O Wiggan; M T Maloney; Barbara W Bernstein; J M Sneider; J A Gonzalez; James R Bamburg
Journal:  Methods Cell Biol       Date:  2003       Impact factor: 1.441

2.  Beta-secretase-cleaved amyloid precursor protein accumulates at actin inclusions induced in neurons by stress or amyloid beta: a feedforward mechanism for Alzheimer's disease.

Authors:  Michael T Maloney; Laurie S Minamide; Andrew W Kinley; Judith A Boyle; James R Bamburg
Journal:  J Neurosci       Date:  2005-12-07       Impact factor: 6.167

3.  Copper binding is the governing determinant of prion protein turnover.

Authors:  Cathryn L Haigh; Kate Edwards; David R Brown
Journal:  Mol Cell Neurosci       Date:  2005-10       Impact factor: 4.314

4.  A cofilin-like protein is involved in the regulation of actin assembly in developing skeletal muscle.

Authors:  H Abe; S Ohshima; T Obinata
Journal:  J Biochem       Date:  1989-10       Impact factor: 3.387

5.  The viral protein gp120 decreases the acetylation of neuronal tubulin: potential mechanism of neurotoxicity.

Authors:  Valeria Avdoshina; Seamus P Caragher; Erin D Wenzel; Francesca Taraballi; Italo Mocchetti; Gaylia Jean Harry
Journal:  J Neurochem       Date:  2017-04-06       Impact factor: 5.372

Review 6.  Peptide regulation of cofilin activity in the CNS: A novel therapeutic approach for treatment of multiple neurological disorders.

Authors:  Alisa E Shaw; James R Bamburg
Journal:  Pharmacol Ther       Date:  2017-02-20       Impact factor: 12.310

Review 7.  Lipid rafts in neurodegeneration and neuroprotection.

Authors:  Sandro Sonnino; Massimo Aureli; Sara Grassi; Laura Mauri; Simona Prioni; Alessandro Prinetti
Journal:  Mol Neurobiol       Date:  2013-12-22       Impact factor: 5.590

8.  Brain ischemic insult induces cofilin rod formation leading to synaptic dysfunction in neurons.

Authors:  Liang Shu; Ben Chen; Bin Chen; Hai Xu; Guoxiang Wang; Yian Huang; Yingya Zhao; Hui Gong; Min Jiang; Lidian Chen; Xu Liu; Yun Wang
Journal:  J Cereb Blood Flow Metab       Date:  2018-06-22       Impact factor: 6.200

Review 9.  Modulation of Chemokine Receptor Function by Cholesterol: New Prospects for Pharmacological Intervention.

Authors:  Daniel F Legler; Christoph Matti; Julia M Laufer; Barbara D Jakobs; Vladimir Purvanov; Edith Uetz-von Allmen; Marcus Thelen
Journal:  Mol Pharmacol       Date:  2017-01-12       Impact factor: 4.436

10.  A NOX2/Egr-1/Fyn pathway delineates new targets for TKI-resistant malignancies.

Authors:  Mary E Irwin; Blake P Johnson; Roxsan Manshouri; Hesham M Amin; Joya Chandra
Journal:  Oncotarget       Date:  2015-09-15
View more
  3 in total

1.  Metabolic Reprogramming in HIV-Associated Neurocognitive Disorders.

Authors:  Charles N S Allen; Sterling P Arjona; Maryline Santerre; Claudio De Lucia; Walter J Koch; Bassel E Sawaya
Journal:  Front Cell Neurosci       Date:  2022-03-28       Impact factor: 5.505

Review 2.  The role of CCR5 in HIV-associated neurocognitive disorders.

Authors:  Cecile Riviere-Cazaux; Jessica Cornell; Yang Shen; Miou Zhou
Journal:  Heliyon       Date:  2022-07-14

Review 3.  Cytoskeletal dysregulation and neurodegenerative disease: Formation, monitoring, and inhibition of cofilin-actin rods.

Authors:  Anna I Wurz; Anna M Schulz; Collin T O'Bryant; Josephine F Sharp; Robert M Hughes
Journal:  Front Cell Neurosci       Date:  2022-09-22       Impact factor: 6.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.